Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer

被引：7
|
作者：
Rasmussen, Maja Lynge [1 ]
Liposits, Gabor [2 ]
Yogendram, Subethini [1 ]
Jensen, Anders Bonde [1 ]
Linnet, Soren [2 ]
Langkjer, Sven Tyge [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark
[2] Herning Hosp, Dept Oncol, Herning, Denmark
来源：
ACTA ONCOLOGICA | 2014年 / 53卷 / 09期
关键词：
D O I：
10.3109/0284186X.2014.918277
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1275 / +
页数：3
相关论文
共 50 条
  • [1] TREATMENT WITH ERIBULIN (HALAVEN) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC BREAST CANCER
    Lynge, M.
    Liposits, G. I.
    Linnet, S.
    Langkjer, S. T.
    BREAST, 2013, 22 : S43 - S43
  • [2] Prognostic and predictive factors of eribulin in patients with heavily pre-treated metastatic breast cancer
    Chen, Pei-Hsin
    Yeh, Dah-Cherng
    Tung, Heng-Hsin
    Lin, Chin-Yao
    MEDICINE, 2021, 100 (47)
  • [3] Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer
    Menis, J.
    Twelves, C.
    BREAST CANCER-TARGETS AND THERAPY, 2011, 3 : 101 - 111
  • [4] Eribulin monotherapy in heavily pre-treated patients with advanced breast cancer: "Real world" experience
    Sanganalmath, P.
    Purohit, K.
    Winter, M.
    Horsman, J.
    Ramakrishnan, S.
    Hatton, M.
    Lee, C.
    Dunn, K.
    Din, O.
    Coleman, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S181 - S182
  • [5] Increased survival for heavily pre-treated metastatic breast cancer
    Siddall, Rhonda
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (07) : 370 - 370
  • [6] Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
    Rupert Bartsch
    Catharina Wenzel
    Simon P. Gampenrieder
    Ursula Pluschnig
    Gabriela Altorjai
    Margaretha Rudas
    Robert M. Mader
    Peter Dubsky
    Andrea Rottenfusser
    Michael Gnant
    Christoph C. Zielinski
    Guenther G. Steger
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 903 - 910
  • [7] Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
    Bartsch, Rupert
    Wenzel, Catharina
    Gampenrieder, Simon P.
    Pluschnig, Ursula
    Altorjai, Gabriela
    Rudas, Margaretha
    Mader, Robert M.
    Dubsky, Peter
    Rottenfusser, Andrea
    Gnant, Michael
    Zielinski, Christoph C.
    Steger, Guenther G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 903 - 910
  • [8] Combination chemotherapy with Cisplatin, etoposide, and ifosfamide as a salvage treatment in heavily pre-treated metastatic breast cancer patients
    Habbel, P.
    Kurreck, A.
    Schulz, C. -O.
    Neumann, C.
    Possinger, K.
    Eucker, J.
    ONKOLOGIE, 2013, 36 : 160 - 160
  • [9] Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series
    Giannone, G.
    Milani, A.
    Ghisoni, E.
    Genta, S.
    Mittica, G.
    Montemurro, F.
    Valabrega, G.
    BREAST, 2018, 38 : 160 - 164
  • [10] Effective Panitumumab Treatment in Patients with Heavily Pre-treated Metastatic Colorectal Cancer: A Case Series
    Tzovaras, Alexandros A.
    Karagiannis, Athanassios
    Margari, Charalambia
    Barla, Georgia
    Ardavanis, Alexandros
    ANTICANCER RESEARCH, 2011, 31 (03) : 1033 - 1037
12345